RecruitingNCT06872905

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease


Sponsor

W.L.Gore & Associates

Enrollment

158 participants

Start Date

May 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The study will assess the safety and effectiveness of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis ("VBX Device" or also referred to as "VBX Stent Graft") in a post approval setting and evaluate the quality of the use in covered endovascular reconstruction of the aortic bifurcation (CERAB) to treat Aortoiliac Occlusive Disease (AIOD).


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria5

  • Patient treated with covered endovascular reconstruction of the aortic bifurcation (CERAB) procedure for aortoiliac occlusive disease (AIOD).
  • Patient was implanted with the VBX Device in the aortic position during a CERAB procedure.
  • Patient was treated with the CERAB procedure a minimum of 1 year before enrollment date.
  • Age ≥18 years at the time of CERAB procedure.
  • Obtain patient informed consent or waiver according to local Institutional Review Board (IRB)/Ethics Committee (EC) -

Exclusion Criteria4

  • Patient with prior stenting in the aortic or common iliac artery at the time of CERAB procedure.
  • Patient treated with concomitant chimney procedure at time of CERAB procedure (e.g., inferior mesenteric artery, renal artery).
  • Participation in another drug or device investigational study at the time of the CERAB procedure date that can confound the study endpoints.
  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEGORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX)

Treatment of Target Lesions with the VBX Device in the aortic and common iliac positions during the CERAB procedure.


Locations(19)

University of California

Fresno, California, United States

University of South Florida

Tampa, Florida, United States

Mayo Clinic Rochester

Rochester, Minnesota, United States

Cooper University Hospital

Camden, New Jersey, United States

Rutgers

New Brunswick, New Jersey, United States

Research Foundation SUNY Buffalo

Buffalo, New York, United States

Mount Sinai Medical Center

New York, New York, United States

Ohio State University Medical Center

Columbus, Ohio, United States

University Of Pennsylvania

Philadelphia, Pennsylvania, United States

Wellmont Holston Valley Medical Center

Kingsport, Tennessee, United States

The University of Texas Austin

Austin, Texas, United States

Carilion Clinic

Roanoke, Virginia, United States

Marshfield Hospital

Marshfield, Wisconsin, United States

Azienda Ospedaliero-Universitaria di Padova

Padova, Italy

Ospedale di Circolo e Fondazione Macchi

Varese, Italy

Amsterdam UMC Research BV

Amsterdam, Netherlands

Franciscus

Rotterdam, Netherlands

Hospital General Universitario de Alicante

Alicante, Spain

Greater Glasgow Health Board

Glasgow, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06872905


Related Trials